Puma Biotechnology reported $12M in Operating Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Agios Pharmaceuticals AGIO:US $ -94.94M 3.5M
Alnylam Pharmaceuticals ALNY:US $ -191.69M 44.95M
Amgen AMGN:US $ 2176M 324M
Biogen BIIB:US $ -59.1M 669.8M
Biomarin Pharmaceutical BMRN:US $ 39.15M 98.18M
Bluebird Bio BLUE:US $ -107.4M 12.95M
Cerulean Pharma CERU:US $ -8400450 1.14M
Clovis Oncology CLVS:US $ -59.38M 9.02M
Daiichi Sankyo 4568:JP Y 34382M 85129M
Esperion Therapeutics ESPR:US $ -52376000 9.39M
Exelixis EXEL:US $ 83.71M 0.46M
Gilead Sciences GILD:US $ 2029M 1832M
Glaxosmithkline GSK:US $ 1081M 1720M
Intercept Pharmaceuticals ICPT:US $ -13.36M 3.09M
Macrogenics MGNX:US $ -41808000 24.83M
Mirati Therapeutics MRTX:US $ -177.2M 7.01M
Moderna Inc MRNA:US 2.45B 1.78B
Novartis NOVN:VX 2.23B 624M
Pfizer PFE:US $ 12102M 2229M
Ptc Therapeutics PTCT:US $ -92.36M 5.84M
Puma Biotechnology PBYI:US $ 12M 12.77M
Regeneron Pharmaceuticals REGN:US $ 1109.9M 148.6M
Sangamo Biosciences SGMO:US $ -45.73M 0.47M
Sarepta Therapeutics SRPT:US $ -211.13M 124.25M
Seattle Genetics SGEN:US $ -133.11M 0.06M
Spectrum Pharmaceuticals SPPI:US $ -25.39M 11.33M
Takeda 4502:JP Y 150515M 152134M
Tg Therapeutics TGTX:US $ -38.94M 27.93M
Ultragenyx Pharmaceutical RARE:US $ -141.59M 4.96M
Vanda Pharmaceuticals VNDA:US $ 3.46M 11.13M
Vertex Pharmaceuticals VRTX:US $ 1106.3M 65.4M
YTE INCY:US $ 254.43M 137.89M